Zaphyr honored at the Economist War on Cancer Middle East Summit 2019

WAR ON CANCER
MIDDLE EAST
Care for all.

March 12th 2019
Dubai

THE-ECONOMIST-032019-1a THE-ECONOMIST-032019-2a THE-ECONOMIST-032019-3a THE-ECONOMIST-032019-4a


Zaphyr CEO, Dr Manel Chikh talking about How can technology improve the patient journey during a panel discussion with other amazing CEOs

Thank you Dr Sawsan Al Madhi, Dr Dominique Joubert and Dr Sharif Kullab for the successful roundtable on the “Latest innovations in oncology treatment: clinical research, screening and treatment in MEA in general and in the GCC in particular”. I was truly honored to moderate this session and highlight with you all the amazing innovations that are being currently launched in the region such as CancerRead test.

2Latest-innovations-in-oncology-treatment1 2Latest-innovations-in-oncology-treatment2 2Latest-innovations-in-oncology-treatment4 2Latest-innovations-in-oncology-treatment3 2Latest-innovations-in-oncology-treatment5 2Latest-innovations-in-oncology-treatment8 2Latest-innovations-in-oncology-treatment7


Zaphyr CEO, Dr Manel Chikh, talking about innovation in Oncology and moderating a very interesting panel discussion during CPhi MEA with amazing experts in the region “Latest innovations in oncology treatment: clinical research, screening and treatment »

Thank you Dr Sawsan Al Madhi, Dr Dominique Joubert and Dr Sharif Kullab for the successful roundtable on the “Latest innovations in oncology treatment: clinical research, screening and treatment in MEA in general and in the GCC in particular”. I was truly honored to moderate this session and highlight with you all the amazing innovations that are being currently launched in the region such as CancerRead test.

Latest-innovations-in-oncology-treatment3 Latest-innovations-in-oncology-treatment2 Latest-innovations-in-oncology-treatment1


Manel Chikh among other excecutive selected members of CPhi Advisory board, Kick the first Cphi Middel east & Africa congress



CPhl middle east & africa 2018 – Manel Chikh – Zaphyr Pharmaceuticals

Manel Chikh zaphyr pharmaceuticalsManel Chikh
Co-Founder and Chief Executive Officer
Zaphyr Pharmaceuticals.
CPhl middle east & africa
(3-5 September 2018 | ADNEC, Abu Dhabi, United Arab Emirates)

By representing each sector of the pharmaceutical industry, CPhI is one of the most important and supportive platforms for pharma companies.
Each CPhI event is an opportunity to meet new key players, to develop YOUR API or finished dose portfolio, to develop and expend manufacturing and/or commercialization capabilities in new territories and to receive updates on all the new trends.

Thanks to CPhI, I met many outstanding partners with whom I built a strong and successful long-term presence in the MEA region.

I fully support and recommend the launch of CPhI MEA. This event will be a fantastic opportunity to highlight the region to the wider pharma market and to give foreign companies real exposure to the potential opportunities it offers. API developers, finished dosage suppliers, CROs and manufacturers will have the chance to build strong relationships with key regional and local players to develop and increase local production, as well as to stimulate imports of high quality, effective medicines in the region.


Zaphyr supports breast awareness campaigns in the MENA

Thank you Nabtha Health for all your amazing activities to increase breast cancer awareness among the MENA region and for inviting Zaphyr CEO to be part of your prestigious & esteemed panel of experts and for the excellent discussion we had live stream.

“Zulekha Hospital
HealthBay Polyclinic
Friends of Cancer Patients – Pink Caravan
#Zaphyr_Pharmaceuticals
Don’t miss your chance! Are you afraid of suddenly developing #breast_cancer ? Are you doing anything that puts you in higher risk without being aware?! Nabta plus a group of specialists will go #LIVE on Sunday 19th of November to answer all your questions about breast cancer! Be there or be square! Exactly on 5:30 #Egypt, 6:30 #KSA & 7:30 #Dubai time! 🌸🌸Get all your questions ready.”
Nabta Health (FB – 17/11/2017)


Zaphyr at the First UAE France Economic Forum

Zaphyr was proud to be selected to be part of the first UAE – French Economic Business Forum held the 9th of November in Dubai with the presence of H.E Benjamin Griveaux.
We had very interesting discussions on innovation in healthcare with amazing partners from both countries.
This high-level Forum aimed to bolster bilateral economic relationship between France and the UAE.
The event was structured with 3 different panels focused on the main pillars of the Dubai Expo 2020: “Opportunity”, “Mobility” and “Sustainability.


CPhi Worldwide congress Interview with Manel Chikh, CEO, Zaphyr Pharma

Manel ChikhWe are proud to share our exclusif CEO interview for CPhi Middle East & Africa

Dr. Manel Chikh is the founder and CEO of Zaphyr Pharmaceuticals, a pharma company that commercialize specialty products in the MEA region. Founded in 2012, Zaphyr focuses on oncology and rare diseases and operates between Switzerland, Ireland and Dubai.

 

Given your expertise in the MEA region, how would you assess the present state of the GCC market and across the wider region ?
The MEA market faced a slowdown last year, primarily driven by the oil crisis in key countries such as Saudi Arabia and Algeria, and currency devaluation and economic crises in other countries, Egypt for example.
Governments across the region reacted by increasing their focus on cost containments impacting the healthcare budget, for example Saudi Arabia reduced the annual tender opportunity for selected products leading to a significant decline in revenues for many international companies operating in the region.
However, recent performance indicators show that many countries are recovering slowly, and we can still anticipate the MEA region to be among the fastest growing pharma market regions globally in the near future. The main revenue driver for the majority of multinational companies will remain the innovative medicines portfolio. However, the companies who will diversify into generics, consumer medicines, diagnostics and other related healthcare markets will find interesting growth opportunities. Generics are expected to represent half of all sales in 2017 and will continue to grow.

What opportunities does the market present in your region ?
Government policies and efforts across the MEA region to reduce drug spending whilst simultaneously improving access to quality and cost effective medicines for patients has resulted in the strong performance of generics. Affordability will be the key consideration for